Pharmabiz1h
Nektar announces clinical trial agreement to evaluate rezpegaldesleukin in patients with new onset type 1 diabetes mellitus
Nektar announces clinical trial agreement to evaluate rezpegaldesleukin in patients with new onset type 1 diabetes mellitus: San Francisco Tuesday, February 25, 2025, 18:00 Hrs [I ...
Pharmabiz2h
US FDA approves label changes for Indivior’s Sublocade injection
Indivior PLC, a global leader in addiction treatment, announced that the US Food and Drug Administration (FDA) has approved label changes for Sublocade including a rapid initiation protocol and ...
Pharmabiz3h
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...
Pharmabiz3h
EY-Parthenon & Microsoft report charts path to enterprise adoption at BioAsia 2025
EY-Parthenon & Microsoft report charts path to enterprise adoption at BioAsia 2025: Our Bureau, Bengaluru Tuesday, February 25, 2025, 16:15 Hrs [IST] EY-Parthenon and Microsoft ha ...
Pharmabiz3h
EMA validates Gilead’s MAA and EU-Medicines for all application for twice-yearly lenacapavir for HIV prevention
Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...
Pharmabiz3h
Manavata Health Campus houses India’s largest robotic parking system in healthcare
Manavata Health Campus houses India’s largest robotic parking system in healthcare: Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:50 Hrs [IST] Manavata Health Campus, com ...
Pharmabiz3h
Biocon Biologics launches Yesintek biosimilar to Stelara in US
Biocon Biologics launches Yesintek biosimilar to Stelara in US: Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:40 Hrs [IST] Biocon Biologics has announced that Yesintek (ust ...
Pharmabiz3h
Meril unveils new surgical products for cardiovascular portfolio
Meril unveils new surgical products for cardiovascular portfolio: Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:30 Hrs ...
Pharmabiz4h
India’s CRDMO growth potential at $22-$25 billion by 2035, driving global pharma innovation: BCG-IPSO Report
Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:15 Hrs [IST] ...
Pharmabiz4h
GSK commences share buyback programme
London, UK Tuesday, February 25, 2025, 15:00 Hrs [IST] GSK plc (GSK) announces the commencement of its share buyback programme (the “Progr ...
Pharmabiz4h
Venus Remedies enters exclusive licensing agreement with Infex Therapeutics to develop and commercialize MET-X in India
Our Bureau, Bengaluru Tuesday, February 25, 2025, 14:45 Hrs [IST] ...
Pharmabiz4h
MedGenome launches campaign ‘Care for the Rare’ to promote early detection of rare diseases
MedGenome launches campaign ‘Care for the Rare’ to promote early detection of rare diseases: Our Bureau, Bengaluru Tuesday, February 25, 2025, 14:30 Hrs [IST] MedGenome, a glo ...